Goldman Sachs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.8M | Buy |
457,900
+250,500
| +121% | +$14.6M | ﹤0.01% | 2129 |
|
|
2025
Q4 | $11.2M | Sell |
207,400
-762,200
| -79% | -$36.7M | ﹤0.01% | 2991 |
|
|
2025
Q3 | $43.7M | Buy |
969,600
+814,200
| +524% | +$38M | 0.01% | 1525 |
|
|
2025
Q2 | $7.19M | Sell |
155,400
-231,200
| -60% | -$11.3M | ﹤0.01% | 3072 |
|
|
2025
Q1 | $23.6M | Sell |
386,600
-118,100
| -23% | -$6.88M | ﹤0.01% | 1869 |
|
|
2024
Q4 | $28.5M | Sell |
504,700
-310,000
| -38% | -$17.3M | ﹤0.01% | 1787 |
|
|
2024
Q3 | $42.2M | Sell |
814,700
-2,140,500
| -72% | -$100M | 0.01% | 1386 |
|
|
2024
Q2 | $123M | Sell |
2,955,200
-332,700
| -10% | -$14.9M | 0.02% | 698 |
|
|
2024
Q1 | $178M | Buy |
3,287,900
+320,700
| +11% | +$16.3M | 0.03% | 538 |
|
|
2023
Q4 | $152M | Buy |
2,967,200
+2,266,500
| +323% | +$119M | 0.03% | 590 |
|
|
2023
Q3 | $40.7M | Buy |
700,700
+538,300
| +331% | +$33M | 0.01% | 1232 |
|
|
2023
Q2 | $10.4M | Buy |
162,400
+108,400
| +201% | +$7.27M | ﹤0.01% | 2414 |
|
|
2023
Q1 | $3.74M | Sell |
54,000
-216,700
| -80% | -$15.3M | ﹤0.01% | 3329 |
|
|
2022
Q4 | $19.5M | Buy |
270,700
+80,900
| +43% | +$6.1M | ﹤0.01% | 1986 |
|
|
2022
Q3 | $13.5M | Sell |
189,800
-104,700
| -36% | -$7.59M | ﹤0.01% | 2227 |
|
|
2022
Q2 | $22.7M | Buy |
294,500
+163,600
| +125% | +$12.5M | 0.01% | 1795 |
|
|
2022
Q1 | $9.56M | Sell |
130,900
-387,000
| -75% | -$26M | ﹤0.01% | 2739 |
|
|
2021
Q4 | $32.3M | Buy |
517,900
+203,200
| +65% | +$11.9M | 0.01% | 1695 |
|
|
2021
Q3 | $18.6M | Buy |
314,700
+207,000
| +192% | +$13.6M | ﹤0.01% | 2129 |
|
|
2021
Q2 | $7.2M | Sell |
107,700
-289,600
| -73% | -$18.9M | ﹤0.01% | 3015 |
|
|
2021
Q1 | $25.1M | Buy |
397,300
+13,500
| +4% | +$840K | 0.01% | 1751 |
|
|
2020
Q4 | $23.8M | Buy |
383,800
+168,300
| +78% | +$10.3M | 0.01% | 1720 |
|
|
2020
Q3 | $13M | Sell |
215,500
-18,400
| -8% | -$1.11M | ﹤0.01% | 2087 |
|
|
2020
Q2 | $13.8M | Buy |
233,900
+54,200
| +30% | +$3.24M | ﹤0.01% | 1997 |
|
|
2020
Q1 | $10M | Sell |
179,700
-930,100
| -84% | -$56.8M | ﹤0.01% | 2081 |
|
|
2019
Q4 | $71.2M | Buy |
1,109,800
+377,600
| +52% | +$21.6M | 0.02% | 909 |
|
|
2019
Q3 | $37.1M | Sell |
732,200
-603,400
| -45% | -$28.4M | 0.01% | 1319 |
|
|
2019
Q2 | $60.6M | Sell |
1,335,600
-575,400
| -30% | -$26.8M | 0.02% | 1016 |
|
|
2019
Q1 | $91.2M | Buy |
1,911,000
+1,362,400
| +248% | +$67.9M | 0.03% | 718 |
|
|
2018
Q4 | $28.5M | Buy |
548,600
+99,700
| +22% | +$5.36M | 0.01% | 1516 |
|
|
2018
Q3 | $27.9M | Sell |
448,900
-768,500
| -63% | -$45.6M | 0.01% | 1672 |
|
|
2018
Q2 | $67.4M | Buy |
1,217,400
+621,100
| +104% | +$33.5M | 0.02% | 1003 |
|
|
2018
Q1 | $37.7M | Sell |
596,300
-113,800
| -16% | -$7.32M | 0.01% | 1378 |
|
|
2017
Q4 | $43.5M | Sell |
710,100
-341,100
| -32% | -$21.3M | 0.01% | 1391 |
|
|
2017
Q3 | $67M | Sell |
1,051,200
-168,300
| -14% | -$9.83M | 0.02% | 1079 |
|
|
2017
Q2 | $68M | Buy |
1,219,500
+224,000
| +23% | +$12.2M | 0.02% | 1043 |
|
|
2017
Q1 | $54.1M | Sell |
995,500
-663,900
| -40% | -$36.4M | 0.01% | 1174 |
|
|
2016
Q4 | $97M | Buy |
1,659,400
+776,000
| +88% | +$42.4M | 0.03% | 792 |
|
|
2016
Q3 | $47.6M | Sell |
883,400
-75,500
| -8% | -$4.85M | 0.01% | 1246 |
|
|
2016
Q2 | $70.5M | Buy |
958,900
+583,600
| +156% | +$41.2M | 0.02% | 876 |
|
|
2016
Q1 | $24M | Sell |
375,300
-390,300
| -51% | -$24.6M | 0.01% | 1588 |
|
|
2015
Q4 | $52.7M | Buy |
765,600
+113,600
| +17% | +$7.51M | 0.02% | 1084 |
|
|
2015
Q3 | $38.6M | Buy |
652,000
+311,000
| +91% | +$19.7M | 0.01% | 1228 |
|
|
2015
Q2 | $22.7M | Sell |
341,000
-23,200
| -6% | -$1.53M | 0.01% | 1696 |
|
|
2015
Q1 | $23.5M | Buy |
364,200
+127,000
| +54% | +$7.95M | 0.01% | 1642 |
|
|
2014
Q4 | $14M | Sell |
237,200
-587,300
| -71% | -$33.1M | ﹤0.01% | 2088 |
|
|
2014
Q3 | $42.2M | Buy |
824,500
+303,500
| +58% | +$15.2M | 0.01% | 1203 |
|
|
2014
Q2 | $25.3M | Sell |
521,000
-626,800
| -55% | -$30.9M | 0.01% | 1615 |
|
|
2014
Q1 | $59.6M | Sell |
1,147,800
-405,100
| -26% | -$21.6M | 0.02% | 924 |
|
|
2013
Q4 | $82.5M | Buy |
1,552,900
+661,400
| +74% | +$33.7M | 0.03% | 727 |
|
|
2013
Q3 | $41.3M | Sell |
891,500
-453,400
| -34% | -$19.9M | 0.02% | 1098 |
|
|
2013
Q2 | $60.1M | Buy |
+1,344,900
| New | +$58.4M | 0.02% | 803 |
|
Other funds holding BMY
VCM
VPM
Goldman Sachs's BMY Position: Q1 2026 in Review
Goldman Sachs reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $250M and leaving 14,054,518 shares worth $852M. The position accounts for 0.1% of the portfolio, ranked #196.
Goldman Sachs first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Goldman Sachs held 14,054,518 shares of Bristol-Myers Squibb worth $852M as of Q1 2026.
- Goldman Sachs sold 4,288,459 Bristol-Myers Squibb shares in Q1 2026, an estimated $250M.
- Bristol-Myers Squibb made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #196 holding.
- Goldman Sachs first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Bristol-Myers Squibb position peaked at $1.19B in Q1 2023.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.